FOXO Technologies Authorizes 150% Increase in Common Stock for Future Dilutive Financings

summarizeSummary

FOXO Technologies has authorized a massive increase in its common stock, from 10 billion to 25 billion shares, to facilitate future financings and satisfy existing conversion obligations, signaling significant potential dilution for current shareholders.

check_boxKey Events

• Massive Increase in Authorized Shares

  The company's Certificate of Incorporation will be amended to increase authorized Class A Common Stock from 10,000,000,000 to 25,000,000,000 shares. This represents a 150% increase in authorized shares.

• Purpose for Capital Raising and Conversions

  The increase is necessary to satisfy existing conversion obligations from preferred stock, convertible debt instruments, and warrants, as well as to provide flexibility for future equity or equity-linked financings and strategic transactions.

• Significant Potential Dilution

  With 3,732,660,939 shares currently outstanding, the authorization of an additional 21,267,339,061 shares (beyond current outstanding) means that if all authorized shares were issued, potential dilution would be approximately 570%.

• Approved by Majority Shareholder

  The Authorized Increase was approved by written consent of Rennova Health, Inc. (controlled by the Company's CEO), which holds approximately 97.59% of the company's voting power, making the action certain.

auto_awesomeAnalysis

FOXO Technologies has authorized a substantial increase in its Class A Common Stock, raising the total from 10 billion to 25 billion shares. This move, approved by a majority shareholder, is critical for the company to meet existing conversion obligations from preferred stock and convertible debt, and to secure future financing. Given the company's current stock price (effectively zero) and recent CFO resignation due to financial reporting concerns, this authorization signals a distressed need for capital that will likely result in significant dilution for existing shareholders. The company is preparing for highly dilutive capital raises to ensure its operational runway.